期刊文献+

慢性阻塞性肺疾病患者血清CRP、IL-6、IL-8、NO与肺功能关系的临床研究 被引量:8

Clinical Research of Relationship between Lung Function and Serum CPR, IL-6, IL-8 and NO in Patients with Chronic Obstructive Pulmonary Disease
下载PDF
导出
摘要 目的探讨慢性阻塞性肺疾病(COPD)患者血清C反应蛋白(CRP)、白细胞介素-6、白细胞介素-8、一氧化氮(NO)与肺功能关系的临床意义。方法采集慢性阻塞性肺疾病急性加重期、缓解期患者和健康者外周血,检测血清CRP、IL-6、IL-8、NO水平,测定肺功能。结果血清CRP、IL-6、IL-8水平比较:急性加重期组明显高于缓解期组,缓解期组明显高于健康对照组,差异均有显着性(P<0.05);血清NO水平和肺功能指标(FEV1%、FEV1/FVC%)比较:急性加重期组明显低于缓解期组,缓解期组明显低于健康对照组,差异有显着性(P<0.05);COPD急性加重期血清CRP、IL-6、IL-8水平与FEV1/预计值%呈负相关(r=-0.812,P<0.05),血清NO水平与FEV1/预计值%呈正相关(r=0.437,P<0.05)。结论 COPD患者血清CRP、IL-6、IL-8、NO的水平与肺功能及病情变化密切相关,血清CRP、IL-6、IL-8、NO的变化可衡量COPD病情严重程度和判断患者的疗效及预后,CRP可作为COPD早期抗感染的参考指标之一。 Objective Explore the clinic significance of CRP,IL-6,IL-8,NO and pulmonary function in patients with COPD.Method Acquire peripheral blood of patients with COPD in acute exacerbation,in catabasis and healthy person.Measure the serum CRP,IL-6,IL-8,NO and lung function.Result Compare serum CRP,IL-6,IL-8: The group of AECOPD is significantly higher than the group of catabasis,and the group of catabasis is significantly higher than the group of healthy person(P0.05);Compare the serum NO and lung function(FEV1%、FEV1/FVC%): group AECOPD is lower than group catabasis,and group catabasis is lower than group healthy person,the difference are significant(P0.05);The level of serum CRP,IL-6,IL-8 are negatively correlated to the value of FEV1/expected value%(r=-0.812,P 0.05).The level of serum NO is positively correlated to the value of FEV1/expected value%(r=0.437,P0.05).Conclusion The level of the serum CRP,IL-6,IL-8,NO and lung function are closely related to the changing of the patient’s conditions.Serum CRP,IL-6,IL-8 can be used to judgd the severity of the illness.They can also be used to estimate the curative effect and prognosis.CRP can be used as one of reference index in resisting infection in early stage of COPD.
出处 《中国医药指南》 2012年第11期45-46,共2页 Guide of China Medicine
关键词 COPD CRP NO 白细胞介素 肺功能 COPD CRP NO IL(interleukin) Lung function
  • 相关文献

参考文献4

二级参考文献27

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2罗南萍,杨道理,孙文杰,陈英剑,张波.肺心病患者血清肿瘤坏死因子的检测[J].临床内科杂志,1996,13(6):23-24. 被引量:2
  • 3Kawahito K, Mohara J, Misawa Y, et al. Assessment of the myocardial protective effect of antegrade warm blood cardioplegia by measuring the release of biochemical markers [J]. Surg Today, 1999, 29 (4) : 322-326.
  • 4Suzuki K, Kazui T, Terada H, et al. Experimental study on the protective effects of edaravone against ischemic spinal cord injury [J]. J Thorac Cardiovase Surg, 2005, 130 (6): 1586-1592.
  • 5Gazoni LM, Tribble CG, Zhao MQ, et al. Pulmonary macrophage inhibition and inhaled nitric oxide attenuate lung ischemiareperfusion injury [J]. Ann Thorac Surg, 2007, 84 (1) 247-253.
  • 6Eppihimer MJ, Granger DN. Ischermia/reperfusion induced leulzocyte-endothelial interaction in postcapillary venules [J]. Shock, 1997, 8 (1): 16-25.
  • 7Yamashita H, Akamine S, Sumida Y, et al. Inhaled nitric oxide attenuates apoptosis in ischemia-reperfusion injury of the rabbit lung[J]. Ann Thorac Surg, 2004, 78 (1): 292-297.
  • 8Morrison DF,Foss DL,Murtaugh MP. Interleukin-10 gene therapy mediated a melioration of bacterial pneumonia[J].Infect-Immun,2000, 68(8)∶4752.
  • 9Ulich TR, Yin S, Guo K, et al. In tracheal injection of endotoxin and cytokine : interleukin - 6 and transforming growth factor beta inhibit acute inflammation[J]. Am J Pathol, 1991, 138∶1097.
  • 10Hasday JD, McCrea SS,et al. Dyserdulation of airway cytokine expression in chronic obstructive pulminary disease and asthma[J]. Am J Respin Care Med,1994,150(supple)∶54.

共引文献8279

同被引文献59

  • 1中华医学会,中华医院管理学会药事管理专业委员会,中国药学会医院药学专业委员会.抗菌药物临床应用指导原则[J].中华医学杂志,2004,84(23):2026-2056. 被引量:141
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8230
  • 3Chang C, Zhu H, Shen N, et al. Utility of the combination of serum highly-sensitive C-reactive protein level at discharge and a risk index in predicting readmiion for acute exacerba- tion of CADPD[J]. J Bras Pneumol, 2014, 40(5): 495.
  • 4Deng Z C, Zhao P, Cao C, et al. C-reactive protein as a prognostic marker in chronic obstructive pulmonary disease [J]. Exp Ther Med, 2014, 7(2): 443.
  • 5Moy M L, Teylan M, Weston N A, et al. Daily step count is associated with plasma C-reactive protein and IL-6 in a US cohort with CJDPD[J]. Chest, 2014, 145(3): 542.
  • 6Aksu F, Capan N, Aksu K, et al. C-reactive protein levels are raised in stable Chronic obstructive pulmonary disease pa- tients independent of smoking behavior and biomass exposure [J]. J Thorac Dis, 2013, 5(4): 414.
  • 7EI-Deek S E, Makhlouf H A, Saleem T H, et al. Surfactant protein D, soluble intercellular adhesion molecule-1 and high- sensitivity C-reactive protein as biomarkers of chronic ob- structive pulmonary disease[J ]. Med Princ Pract, 2013, 22 (5) : 469.
  • 8Biljak V R, Rumora L, Cepelak I, et al. Gamma-glutamyl- transferase and C-reactive protein in stable chronic obstructive pulmonary disease[J]. Coil Antropol, 2013, 37(1): 221.
  • 9Firouzjahi A, Monadi M, Karimpoor F, et al. Serum C-reac- tive protein level and distribution in chronic obstructive pul- monary disease versus healthy controls: a ease-control study from Iran[J]. Inflammation, 2013, 36(5): 1122.
  • 10Van Dijk W D, Akkerrnans R, Heijdra Y, et al. The acute effect of cigarette smoking on the high-sensitivity CRP and fibrinogen biomarkers in chronic obstructive pulmonary dis- ea patients[J]. Biomark Med, 2013, 7(2): 211.

引证文献8

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部